Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
11 pending office actions • 10 art units • 10 examiners • 2 of 11 (18%) have an AI response strategy ready • 21 patents granted in the last 365 days
Bausch + Lomb Ireland Limited has 11 pending office actions in Medical Devices & Mechanical Engineering. The docket covers 10 distinct examiners and 10 distinct art units, showing that nearly every active matter follows a separate examiner and art-unit path.
DELCOTTO, GREGORY R is the busiest examiner, with 2 pending matters. The low concentration around the busiest examiner places greater emphasis on managing diverse examination practices rather than relying on a single examiner-focused strategy.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (45%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 5 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DELCOTTO, GREGORY R | 2 | 54.1% | +75.7% |
| CHEUNG, CHUN HOI | 1 | 62.4% | +39.1% |
| MARCETICH, ADAM M | 1 | 72.8% | +18.8% |
| GEIGER, RACHAEL L | 1 | 82.3% | +18.3% |
| SPAMER, DONALD R | 1 | 59.4% | +32.3% |
| WARD, PAUL V | 1 | 83.2% | -12.2% |
| BLEDSOE, JOSHUA CALEB | 1 | 43.9% | +45.8% |
| KIM, CRAIG SANG | 1 | 86.4% | +9.9% |
| GALSTER, SAMUEL LEONARD | 1 | 52.1% | +42.2% |
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18377451 | Infusion Sleeve For Phacoemulsification | KIM, CRAIG SANG | 9d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19054362 | CONTACT LENS BLISTER PACKAGING ARRANGEMENT AND METHODS | CHEUNG, CHUN HOI | — |
| 18862267 | VENTED MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM | MARCETICH, ADAM M | — |
| 18903180 | OPHTHALMIC INSERTION TOOL INCLUDING INTEGRAL SCLERAL MARKER | GEIGER, RACHAEL L | — |
| 18786806 | PACKAGING SOLUTIONS | SPAMER, DONALD R | — |
| 18597497 | METHODS FOR TREATING OCULAR SURFACE PAIN | WARD, PAUL V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17905924 | COMPOSITIONS AND METHODS FOR EYE HEAL TH COMPRISING AREDS AND VITAMIN B COMPLEX | SAEED, ALI S | 1d overdue |
| 18422196 | SILICONE HYDROGELS | BLEDSOE, JOSHUA CALEB | 12d |
| 17905913 | COMPOSITIONS AND METHODS FOR AGE RELATED EYE DISEASES COMPRISING HIGH CONCENTRATIONS OF VITAMINS | GALSTER, SAMUEL LEONARD | 53d |
| 19054362 | CONTACT LENS BLISTER PACKAGING ARRANGEMENT AND METHODS | CHEUNG, CHUN HOI | — |
| 18862267 | VENTED MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM | MARCETICH, ADAM M | — |
| 18903180 | OPHTHALMIC INSERTION TOOL INCLUDING INTEGRAL SCLERAL MARKER | GEIGER, RACHAEL L | — |
| 18786806 | PACKAGING SOLUTIONS | SPAMER, DONALD R | — |
| 18374208 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | — |
| Art Unit | Apps |
|---|---|
| 1761 | 2 |
| 3736 | 1 |
| 3781 | 1 |
| 3771 | 1 |
| 1799 | 1 |
| 1622 | 1 |
| 1762 | 1 |
| 3741 | 1 |
| 1693 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19054362 | CONTACT LENS BLISTER PACKAGING ARRANGEMENT AND METHODS | CHEUNG, CHUN HOI | 3736 | §103§112 | Non-Final OA | — | Pending | Feb 14, 2025 |
| 18862267 | VENTED MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM | MARCETICH, ADAM M | 3781 | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18903180 | OPHTHALMIC INSERTION TOOL INCLUDING INTEGRAL SCLERAL MARKER | GEIGER, RACHAEL L | 3771 | §102§103 | Final Rejection | — | Pending | Oct 01, 2024 |
| 18786806 | PACKAGING SOLUTIONS | SPAMER, DONALD R | 1799 | §102§103§112 | Final Rejection | — | Pending | Jul 29, 2024 |
| 18597497 | METHODS FOR TREATING OCULAR SURFACE PAIN | WARD, PAUL V | 1622 | §102§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18422196 | SILICONE HYDROGELS | BLEDSOE, JOSHUA CALEB | 1762 | §103 | Non-Final OA | 12d | Pending | Jan 25, 2024 |
| 18377451 | Infusion Sleeve For Phacoemulsification | KIM, CRAIG SANG | 3741 | §103 | Non-Final OA | 9d | Pending | Oct 06, 2023 |
| 18374208 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | 1761 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18374211 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | 1761 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 17905913 | COMPOSITIONS AND METHODS FOR AGE RELATED EYE DISEASES COMPRISING HIGH CONCENTRATIONS OF VITAMINS | GALSTER, SAMUEL LEONARD | 1693 | §103Other | Final Rejection | 53d | AI Ready | Sep 08, 2022 |
| 17905924 | COMPOSITIONS AND METHODS FOR EYE HEAL TH COMPRISING AREDS AND VITAMIN B COMPLEX | SAEED, ALI S | 1616 | §103§112DP | Non-Final OA | 1d overdue | AI Ready | Sep 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBausch + Lomb Ireland Limited has 11 pending office actions as of October 2026, spread across 10 art units and 10 examiners.
Gregory R Delcotto has the most, with 2 of Bausch + Lomb Ireland Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
